Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment

Bibliographic Details
Main Authors: Marjan Azin, Andrew B. Mahon, Steven Isaacman, Julia E. Seaman, Isabel E. Allen, Michael Szarek, Lynn A. Cornelius, Shadmehr Demehri
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:JID Innovations
Online Access:http://www.sciencedirect.com/science/article/pii/S2667026722000108
_version_ 1811258089282732032
author Marjan Azin
Andrew B. Mahon
Steven Isaacman
Julia E. Seaman
Isabel E. Allen
Michael Szarek
Lynn A. Cornelius
Shadmehr Demehri
author_facet Marjan Azin
Andrew B. Mahon
Steven Isaacman
Julia E. Seaman
Isabel E. Allen
Michael Szarek
Lynn A. Cornelius
Shadmehr Demehri
author_sort Marjan Azin
collection DOAJ
first_indexed 2024-04-12T18:08:50Z
format Article
id doaj.art-0ed6b915684f49cea61948ac8b259b9b
institution Directory Open Access Journal
issn 2667-0267
language English
last_indexed 2024-04-12T18:08:50Z
publishDate 2022-05-01
publisher Elsevier
record_format Article
series JID Innovations
spelling doaj.art-0ed6b915684f49cea61948ac8b259b9b2022-12-22T03:21:54ZengElsevierJID Innovations2667-02672022-05-0123100104Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis TreatmentMarjan Azin0Andrew B. Mahon1Steven Isaacman2Julia E. Seaman3Isabel E. Allen4Michael Szarek5Lynn A. Cornelius6Shadmehr Demehri7Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Immunology, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Research, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USAPHD Biosciences, San Diego, California, USAPHD Biosciences, San Diego, California, USABay View Analytics, Oakland, California, USABay View Analytics, Oakland, California, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USASchool of Public Health, SUNY Downstate Health Sciences University, Brooklyn, New York, USA; CPC Clinical Research, Aurora, Colorado, USA; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USADivision of Dermatology, John T. Milliken Department of Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USACutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Immunology, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Research, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Corresponding authorhttp://www.sciencedirect.com/science/article/pii/S2667026722000108
spellingShingle Marjan Azin
Andrew B. Mahon
Steven Isaacman
Julia E. Seaman
Isabel E. Allen
Michael Szarek
Lynn A. Cornelius
Shadmehr Demehri
Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
JID Innovations
title Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
title_full Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
title_fullStr Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
title_full_unstemmed Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
title_short Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
title_sort topical calcipotriol plus 5 fluorouracil immunotherapy for actinic keratosis treatment
url http://www.sciencedirect.com/science/article/pii/S2667026722000108
work_keys_str_mv AT marjanazin topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment
AT andrewbmahon topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment
AT stevenisaacman topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment
AT juliaeseaman topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment
AT isabeleallen topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment
AT michaelszarek topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment
AT lynnacornelius topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment
AT shadmehrdemehri topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment